Cargando…

Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome

Recent advances in neurobiology have provided several molecular entrees for targeted treatments for Fragile X syndrome (FXS). However, the efficacy of these treatments has been demonstrated mainly in animal models and has not been consistently predictive of targeted drugs’ response in the prepondera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jasoliya, Mittal, Bowling, Heather, Petrasic, Ignacio Cortina, Durbin-Johnson, Blythe, Klann, Eric, Bhattacharya, Aditi, Hagerman, Randi, Tassone, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349631/ https://www.ncbi.nlm.nih.gov/pubmed/32531912 http://dx.doi.org/10.3390/brainsci10060361

Ejemplares similares

Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome
por: Jasoliya, Mittal, et al.
Publicado: (2022)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder
por: Alolaby, Reem Rafik, et al.
Publicado: (2020)

Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS)
por: Zafarullah, Marwa, et al.
Publicado: (2020)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases
por: Protic, Dragana, et al.
Publicado: (2019)

Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2023)

Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment
por: Rajaratnam, Akash, et al.
Publicado: (2020)

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Clinical and molecular correlates in fragile X premutation females
por: Jiraanont, Poonnada, et al.
Publicado: (2017)

Metformin treatment in young children with fragile X syndrome
por: Biag, Hazel Maridith B., et al.
Publicado: (2019)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2023)

Genomic studies in fragile X premutation carriers
por: Lozano, Reymundo, et al.
Publicado: (2014)

Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2021)

Neural progenitor cells from an adult patient with fragile X syndrome
por: Schwartz, Philip H, et al.
Publicado: (2005)

FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability
por: Roth, Mark, et al.
Publicado: (2021)

Intranuclear inclusions in a fragile X mosaic male
por: Pretto, Dalyir I, et al.
Publicado: (2013)

FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Zafarullah, Marwa, et al.
Publicado: (2020)

Sequencing the unsequenceable: Expanded CGG-repeat alleles of the fragile X gene
por: Loomis, Erick W., et al.
Publicado: (2013)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size?
por: Manor, Esther, et al.
Publicado: (2017)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022)

Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome
por: Stöger, Reinhard, et al.
Publicado: (2011)

Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome
por: Johnson, Devon, et al.
Publicado: (2022)

Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses
por: Careaga, Milo, et al.
Publicado: (2014)

Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
por: Careaga, Milo, et al.
Publicado: (2014)

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
por: Chonchaiya, Weerasak, et al.
Publicado: (2010)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Clinical implications of somatic allele expansion in female FMR1 premutation carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)

Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
por: Wang, Jun Yi, et al.
Publicado: (2022)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
por: Hagerman, Randi, et al.
Publicado: (2010)

Fragile X Premutation: Medications, Therapy and Lifestyle Advice
por: Sodhi, Deepika Kour, et al.
Publicado: (2021)

Molecular Biomarkers in Fragile X Syndrome
por: Zafarullah, Marwa, et al.
Publicado: (2019)

Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome
por: Greco, Claudia M, et al.
Publicado: (2011)

A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
por: Hessl, David, et al.
Publicado: (2008)

Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding
por: Napoli, Eleonora, et al.
Publicado: (2016)

Cardiovascular Problems in the Fragile X Premutation
por: Tassanakijpanich, Nattaporn, et al.
Publicado: (2020)

Modulation of the GABAergic pathway for the treatment of fragile X syndrome
por: Lozano, Reymundo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l258j1mr9l8glsv5oejt18i8st